FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization

FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization

Passive immunization with anti-D can prevent maternal alloimmunization to RhD thereby preventing hemolytic disease of the fetus and newborn. Unexpectedly, anti-D fails in some cases and some monoclonal anti-D preparations paradoxically enhances alloimmunization. The underlying mechanisms modulating...

Full description

Bibliographic Details
Main Authors:	Annie Qiu, Anabel Miller, Flavia Dei Zotti, Manjula Santhanakrishnan, Jeanne E. Hendrickson, Maria Tredicine, Sean R. Stowell, Chance John Luckey, James C. Zimring, Krystalyn E. Hudson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	Fc receptor antibody red blood cell alloantibody antibody mediated enhancement
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.972723/full

Similar Items

Antibodies to Low-Copy Number RBC Alloantigen Convert a Tolerogenic Stimulus to an Immunogenic Stimulus in Mice
by: Arijita Jash, et al.
Published: (2021-03-01)

Red cell alloimmunization in repeatedly transfused patients
by: Dimel K Bhuva, et al.
Published: (2017-01-01)

Alloimmunization in dogs after transfusion: A serial cross‐match study
by: Lisa Herter, et al.
Published: (2022-09-01)

IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice
by: Paurvi Shinde, et al.
Published: (2020-07-01)

Systematic analysis of Fc mutations designed to reduce binding to Fc-gamma receptors
by: Geoff Hale, et al.
Published: (2024-12-01)

Identification of anti-c, E alloantibodies with autoantibodies mimicking anti-c, E alloantibodies
by: Kangle Feng, et al.
Published: (2025-01-01)

Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors
by: Geoff Hale, et al.
Published: (2024-12-01)

Editorial: Antibody Fc Engineering: Towards Better Therapeutics
by: Cheng Lei, et al.
Published: (2018-10-01)

The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs
by: Amanda L. Richards, et al.
Published: (2018-10-01)

Antigen–antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function
by: Tanusya Murali Murali, et al.
Published: (2024-12-01)

Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21
by: Claire Dickson, et al.
Published: (2018-04-01)

Alloimmunization among transfusion-dependent thalassemia patients
by: Sadeghian Mohammad, et al.
Published: (2009-01-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
by: Alan L. Schmaljohn, et al.
Published: (2019-07-01)

Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection
by: Dorien De Vlieger, et al.
Published: (2019-12-01)

Systematic approach in identification and management of multiple alloantibody: A case of triple alloantibody
by: Samrat Thapa, et al.
Published: (2019-01-01)

Clinical significance of establishing a red blood cell alloantibody detection database
by: XIAO Xiao, et al.
Published: (2025-01-01)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
by: Andréa Cottignies-Calamarte, et al.
Published: (2023-02-01)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
by: Ahmed M. Khalil, et al.
Published: (2023-07-01)

Antibodies to Senescent Antigen and C3 Are Not Required for Normal Red Blood Cell Lifespan in a Murine Model
by: Krystalyn E. Hudson, et al.
Published: (2017-10-01)

Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
by: Elisabeth A. van Erp, et al.
Published: (2019-03-01)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
by: Shamus P. Keeler, et al.
Published: (2021-05-01)

Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization
by: Abhinav Arneja, et al.
Published: (2016-11-01)

Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
by: Delphine Valente, et al.
Published: (2020-01-01)

Understanding Fc function for rational vaccine design against pathogens
by: Kathryn A. Bowman, et al.
Published: (2024-01-01)

Alloimmunization in thalassemia patients: New insight for healthcare
by: Ali Davoudi-Kiakalayeh, et al.
Published: (2017-01-01)

Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model
by: Miriam Manook, et al.
Published: (2021-06-01)

Red blood cell alloimmunization in Iran: A Comprehensive review of the literature
by: Maryam Sadat Hosseini, et al.
Published: (2020-01-01)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01)

Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering
by: Yuji Hori, et al.
Published: (2022-12-01)

IgG Fc engineering to modulate antibody effector functions
by: Xinhua Wang, et al.
Published: (2017-10-01)

Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice
by: Vicente Escamilla-Rivera, et al.
Published: (2021-06-01)

Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG
by: Andrew R. Crowley, et al.
Published: (2023-12-01)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
by: Bruce D. Wines, et al.
Published: (2021-10-01)

Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial
by: Carolyn M. Boudreau, et al.
Published: (2022-02-01)

Editorial: Roles of Fc Receptors in Disease and Therapy
by: Latha P. Ganesan, et al.
Published: (2020-06-01)

Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
by: Chunpeng Yang, et al.
Published: (2018-01-01)

Red cell alloimmunization in multi-transfused, oncology patients: Risks and management
by: Sadhana Mangwana, et al.
Published: (2019-01-01)

Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection
by: M. Muenchhoff, et al.
Published: (2020-12-01)